As of Nov 25
| +0.07 / +2.34%|
The 5 analysts offering 12-month price forecasts for Solazyme Inc have a median target of 3.15, with a high estimate of 5.00 and a low estimate of 2.00. The median estimate represents a +2.94% increase from the last price of 3.06.
The current consensus among 5 polled investment analysts is to Hold stock in Solazyme Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.